Pathology/oncology Flashcards

1
Q

Describe Bone lesions by patient age:

Table 9.1

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of tumor bone interactions:

Tabie 9.2

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Figure 9.4:

Distributions of varius lesions in patients less than 30

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Figure 9.4B

Distribution of varius bone lesions in patients older than 30

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classification of Primary Tumors of Bone and Bone Matrix:

Table 9.3

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tumors by Location:

Table 9.4

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Principles of Biopsy:

Table 9.5

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Immunohistochemistry and molecular testing for bone and Soft tissue Tumors:

Table 9.6

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Common Chomosomal translocations in Bone and Soft Tissue Tumors:

Table 9.7

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Musculoskeletal Syndromes, Genes, and Neoplasms:

Table 9.8

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Histologic grading of soft tissue tumors:

Table 9.9

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Staging System; Enneking System

Table 9.10

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

American Joint Committee on Cancer Staging System for primary malignant tumors of bone for those tumors diagnosed on or after Jan 1 2010:

Table 9.11

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

American Joint Committee on Cancer staging system for primary malignant tumors of soft tissue for those tumors diagnosed on or after Jan 1,2010:

Table 9.12

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment regimens for malignant bone tumors:

Table 9:13

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Chemotherapy for bone sarcomas:

Table 9.14

A
17
Q

Radiation Therapy for soft tissue sarcoma:

Table 9.15

A
18
Q

Most Common MSK tumors:

table 9.16

A
19
Q

Key points about soft tissue sarcomas:

A

A mass that is more than 5cm, growing and deep to the fascia should be presumed to be a soft tissue sarcoma.–image with MRI.

MRI is the best imaging modality

CT of the chest is performed to evaluate for mets

ESARC–STS with mets to lymph nodes—5% of STS

Epitheloid, Synovial, Angiosarcoma, Rhabdomyosarcoma, Clear cell

20
Q

Table 9.22

Cartilage tumors

A
21
Q

why do I have to learn about Ollier and Mafucci Syndrome?

A

Ollier disease/Maffucci syndrome

When there are many lesions, the involved bones are dysplastic, and the lesions tend toward unilaterality, the diagnosis is multiple enchondromatosis, or Ollier disease.

Inheritance pattern is sporadic.

If soft tissue angiomas are also present, the diagnosis is Maffucci syndrome.

Patients with multiple enchondromatosis are at increased risk of malignancy (in Ollier disease, 30%; in Maffucci syndrome, 100%).

Patients with Maffucci syndrome also have a markedly increased risk of visceral malignancies, such as astrocytomas and gastrointestinal malignancies.

22
Q

why do I have to learn about MHE or multiple Heridetary Exostoses?

A

Multiple hereditary exostoses

The osteochondromas in MHE are often sessile and large. This is an autosomal dominant condition with mutations in the EXT1 and EXT2 gene loci. In approximately 10% of patients with multiple exostoses, a secondary chondrosarcoma develops. The EXT1 mutation is associated with a greater burden of disease and higher risk of malignancy.

23
Q

Describe a chondroblastoma:

A

Centered in the epiphysis in young patients, usually with open physes; it may also occur in an apophysis

Pain referable to the involved joint

The most common locations are the distal femur, proximal tibia, and proximal humerus.

Imaging Shows a central region of bone destruction that is usually sharply demarcated from the normal medullary cavity by a thin rim of sclerotic bone

Histology

The basic proliferating cells are thought to be chondroblasts.

Scattered multinucleated giant cells are found throughout the lesion.Zones of chondroid are present.Mitotic figures may be found.

Treatment: Intralesional resection with curettage and reconstruction

Differential diagnosis: Brodie’s abscess and giant cell tumor of bone

Less than 5% mets to the lungs

24
Q

Epiphyseal Lesions:

Table 9.23

A
25
Q

Describe a chondromyxoid fibroma

A
26
Q

Describe a chondrosarcoma

A

Presentation

Pain or a mass in adults over 50 years old

Most common locations include flat bones (e.g., the scapula), pelvis, and spine.

Imaging

Radiographs usually yield diagnostic findings, with bone destruction, thickening of the cortex, and mineralization consistent with cartilage within the lesion (see Fig. 9.16).

Prominent cortical changes (endosteal scalloping and erosion) are present in 85% of affected patients.

Histology-Differentiating malignant cartilage may be extremely difficult on the basis of histologic features alone.

The clinical, radiographic, and histologic features must be considered in combination for an accurate diagnosis. Criteria for the diagnosis of malignancy include the following:

Many binucleate cells with plump nuclei

Particularly large cartilage cells with large single or multiple nuclei containing clumps of chromatin-Infiltration of the bone trabeculae

Chondromas of the hand (enchondromas)—the lesions in patients with Ollier disease and Maffucci syndrome—and periosteal chondromas may have atypical histopathologic features.

Treatment: Wide surgical resection

Chemotherapy has not been shown to improve survival.

Dedifferentiated chondrosarcoma: The most malignant cartilage tumor

Presentation

Pain and decreased motion.

Most common locations include the distal and proximal femur and the proximal humerus.

Imaging: Biomorphic appearance with that of a typical chondrosarcoma with a superimposed, highly destructive area

Histology: Low-grade cartilage component that is intimately associated with a high-grade spindle cell sarcoma (osteosarcoma, fibrosarcoma, MFH)

Treatment: Wide-margin surgical resection and multiagent chemotherapy

Other features: Prognosis is poor, and rate of long-term survival is less than 10%.

27
Q

Blue Cells-

Learn em

Table 9.24

A
28
Q

Key considerations for lymphoma of bone

Non-Hodgkins Lymphoma

A

Presentation:

Pain in patients of all ages.

The most common locations include the distal femur, proximal tibia, pelvis, proximal femur, vertebra, and shoulder girdle.

Imaging:

Images often show a lesion that involves a large portion of the bone

•Bone destruction is common and often has a mottled appearance.

A large soft tissue mass out of proportion to the amount of bone destruction is characteristic of lymphoma of bone.

Histology: A mixed cellular infiltrate is usually present. Most lymphomas of bone are diffuse, large B-cell lymphomas.

Immunohistochemistry: CD45 and leukocyte common antigen (LCA) positive.

Treatment: Multiagent chemotherapy ( [CHOP]) is curative.

Surgery is used only to stabilize fractures.

29
Q

multiple Myeloma

A

Plasma cell dyscrasias represent a wide range of conditions from monoclonal gammopathy of undetermined significance (MGUS; Kyle disease) to multiple myeloma.

Three plasma cell dyscrasias pertain to orthopaedic surgery: multiple myeloma, solitary plasmacytoma of bone, and osteosclerotic myeloma.

Multiple myeloma:

Malignant plasma cell disorder that commonly occurs in patients between 50 and 80 years of age

Presentation: Manifests with bone pain, usually in the spine and ribs, or as a pathologic fracture

Fatigue is a common complaint secondary to the associated anemia.

Symptoms may be related to complications such as renal insufficiency, hypercalcemia, and the deposition of amyloid.

Serum creatinine values are elevated in about 50% of affected patients.

Hypercalcemia is present in about 33% of affected patients.

Imaging: Radiographic appearance is of punched-out, lytic lesions which may show expansion and a “ballooned” appearance.

Histology:

Sheets of plasma cells that appear monoclonal with immunostaining

Well-differentiated plasma cells have eccentric nuclei that have peripherally clumped, chromatic “clock faces.”

Treatment

Systemic therapy and bisphosphonates

Surgical stabilization with irradiation is used for pathologic fractures.

Radiotherapy is also used for palliation of pain and treatment of neurologic symptoms.

The prognosis is related to the stage of disease; the overall median survival time is 18–24 months.

30
Q

Solitary Plasmocytoma of bone

A

It is important to differentiate solitary myeloma from multiple myeloma because of the more favorable prognosis in patients with the solitary form. Diagnostic criteria include the following:

A solitary lesion on skeletal survey

Histologic confirmation of plasmacytoma

Bone marrow plasmacyte count of 10% or less

Patients with serum protein abnormalities and Bence Jones proteinuria (protein levels <1 g/24 hr) at presentation are not excluded if they meet the aforementioned criteria.

Treatment

External beam irradiation of the lesion (4500–5000 cGy)

When necessary, prophylactic internal fixation

In approximately 50%–75% of affected patients, solitary myeloma progresses to multiple myeloma.

31
Q

Giant Cell Tumor

A

Presentation

Pain and pathologic fracture

Patients over 30 years old with closed physes

Most common in the epiphysis and metaphysis of long bones, and about 50% of lesions occur about the knee; the vertebra, sacrum, and distal radius are involved in about 10% of cases.

The sacrum is the most common axial location of giant cell tumors of bone.

Imaging: A purely lytic destructive lesion in the metaphysis that extends into the epiphysis and often borders the subchondral bone

Histology

Basic proliferating cell has a round to oval or even spindle-shaped nucleus, and the multinucleated giant cells appear to have the same nuclei as the proliferating mononuclear cells. The stromal cell directs the multinucleated giant cell.

Stromal malignant cells produce RANKL (receptor activator for nuclear factorκB ligand).Multinucleated giant cells express RANK and are responsible for the osteolytic aspect of GCT.

Treatment:Aimed at removing the lesion, with preservation of the involved joint

Denosumab (Prolia), a human monoclonal antibody that binds RANKL, thereby inhibiting the maturation of osteoclasts.

Extensive intralesional resection (removal of a large cortical window over the lesion) is performed using curettage with manual and power instruments.

Chemical cauterization may be used (phenol, peroxide).

Area of defect is usually reconstructed with subchondral bone grafts, methylmethacrylate, or both.

Local control with this treatment regimen has a success rate of 85%–90%.

Other features: GCT is described as benign but is aggressive, because in rare cases (<5%) it metastasizes to the lungs.

32
Q

Ewings Sarcoma

A

Presentation

Patient age less than 30 years

Pain and fever may be present; the presentation can be similar to that in an infection.

Patients may exhibit elevated ESR, leukocytosis, anemia, and elevated WBC count.

Most common locations include the pelvis, distal femur, proximal tibia, femoral diaphysis, and proximal humerus.

Imaging

Radiographs often show a large, destructive lesion that involves the metaphysis and diaphysis.

The lesion may be purely lytic or may have variable amounts of reactive new bone formation (Fig. 9.24).

The periosteum may be lifted off in multiple layers, producing a Codman triangle and an onion-skin appearance.

The soft tissue component is distinctively large.

Histology

Small round blue cells with minimal cytoplasm, pseudorosettes (attempted formation of vascular channels)

Immunohistochemistry: CD99 positivity.

A classic 11:22 chromosomal translocation produces the EWS-FLI1 fusion gene.

Bone marrow biopsy is performed for staging purposes.

Treatment: A multimodality approach with multiagent chemotherapy, irradiation, and surgical resection

Standard treatment includes chemotherapy.

Standard for local tumor control is surgery.

Radiation therapy may be used primarily for pelvic and spine disease, where resection would be morbid, or as an adjunct to surgery to maintain function while sparing critical structures.

Differential diagnosis: When a small blue cell tumor is found in a child younger than 5 years, metastatic neuroblastoma and leukemia should be considered.

Other features

Survival

The rate of long-term survival with multimodality treatment may be as high as 60%–70%.

There is a consistent chromosomal translocation (11;22) with the formation of a fusion protein (EWS-FLI1).

Metastatic disease involves the lungs (50%), bone (25%), and bone marrow (20%).

Poor prognostic factors include the following:

Spine and pelvic tumors

Tumors greater than 100 cm3 in diameter

A poor response to chemotherapy (<90% tumor cell necrosis)

Elevated serum LDH (Temple)

The p53 mutation and gene fusion products other than EWS-FLI1

33
Q

Adamantinoma

A

Rare low-grade, malignant tumor of long bones that contains epithelium-like islands of cells

Presentation

Patient less than 30 years old with prolonged periods of pain

The tibia is the most common site; other long bones can be but rarely are involved (fibula, femur, ulna, radius).

Imaging: Radiographic appearance: multiple, sharply circumscribed, “soap bubble”–looking lucent defects of different sizes, with sclerotic bone interspersed between the zones and extending above and below the lucent zones one of the lesions in the midshaft is the largest and is associated with cortical bone destruction.

Histology: Cells have an epithelial quality and are arranged in a palisading or glandular pattern; the epithelial cells occur in a fibrous stroma.

Treatment: Wide-margin surgical resection

Other features: Tumor may metastasize either early or after multiple failed attempts at local control.

34
Q

ABC vs UBC

Figure 9.25

A
35
Q

ABC

A

Nonneoplastic reactive condition that may be aggressive in its ability to destroy normal bone and expand into the soft tissues

Presentation: Patients are less than 30 years old and present with pain and swelling.

Imaging

Characteristic radiographic finding: an eccentric, lytic, expansile area of bone in the metaphysis with a thin rim of periosteal new bone surrounding the lesion. The lesion is wider than the physis of the bone it is closest to (Fig. 9.25 inTable 9.25).

MRI usually shows the periosteal layer surrounding the lesion.

Fluid-fluid levels visible on T2-weighted MRI are characteristic of, but not exclusive to, ABC.

Histology

Cavernous blood-filled spaces without an endothelial lining.

Thin strands of bone are present in the fibrous tissue of the septa.

Benign giant cells may be numerous.

Treatment: Curettage and reconstruction, which may include bone grafting or fixation in the setting of a fracture.

Differential diagnosis: Unicameral bone cyst, telangiectatic osteosarcoma

Other features

Local recurrence is common in children with open physes.

ABC may arise primarily in bone or may be found in association with other tumors, such as giant cell tumor, chondroblastoma, chondromyxoid fibroma, and fibrous dysplasia.

36
Q

UBC

A

Presentation

Patient less than 30 years old presents with pain, usually after a fracture caused by minor trauma (e.g., sporting event, throwing a baseball, wrestling).

Occurs most often in the proximal humerus; other sites are the proximal femur and distal tibia.

Imaging

Symmetric cystic expansion with thinning of the involved cortices

Affected bone is often expanded; however, the bone is generally no wider than the physis.

Often appears trabeculated

When the cyst abuts the physeal plate, the process is called active; when normal bone intervenes, the cyst is termed latent.

Histology: Thin, fibrous lining contains fibrous tissue, giant cells, hemosiderin pigment, and a few chronic inflammatory cells.

Treatment

Asymptomatic: Observation

Symptomatic: Aspiration and injection (bone aspirate, bone graft substitute, or methylprednisolone acetate may be used)

Unicameral bone cysts in high-stress areas (e.g., proximal femur) are often treated with curettage, grafting, and internal fixation to avoid fracture and osteonecrosis.

37
Q

Fibrous Dysplasia:

A

Developmental abnormality of bone that is characterized by monostotic or polyostotic involvement and is the failure of the production of normal lamellar bone.

Presentation

Pain from a fracture or stress fracture; or an incidental finding if asymptomatic; café au lait spots with irregular borders (resembling the coast of Maine) may accompany the bone lesions.

Any bone may be involved; the proximal femur is the most commonly affected.

Imaging: Variable appearance that can look highly lytic or like ground glass

Histology

Well-defined rim of sclerotic bone

Proliferation of fibroblasts (produces a dense collagenous matrix)

Trabeculae of osteoid and bone within the fibrous stroma are present in a disorganized manner, and their appearance has been likened to “alphabet soup” and “Chinese letters.”

Treatment

Predicated on the presence of symptoms and the risk of fracture

Internal fixation and bone grafting are used in areas of high stress in which nonoperative treatment would not be effective.

Most affected patients do not need surgical treatment.

Autogenous cancellous bone grafting is never used because the transplanted bone is quickly transformed into the woven bone of fibrous dysplasia. Cortical or cancellous allografts are usually used.

Bisphosphonate therapy has been shown to be effective in decreasing pain and reducing bone turnover in patients with polyostotic fibrous dysplasia.

Other features

Genetic mutation is an activating mutation of the GSα surface protein (GNAS)

Increased production of cAMP

When endocrine abnormalities (especially precocious puberty) accompany multiple bone lesions and skin abnormalities, the condition is called McCune-Albright syndrome.

38
Q

Lahngerhans Histocytosis

A

Occurs as three entities:

LCH monostotic, also known as eosinophilic granuloma. Only a single bone or, on occasion, multiple bones involved. Most common.

LCH polyostotic plus visceral disease, or Hand-Schüller-Christian disease

LCH polyostotic plus visceral disease in an infant, or Letterer-Siwe disease

The cellular abnormality is a proliferation of the Langerhans cells of the dendritic system.

LCH monostotic

Presentation: Pain and swelling

Imaging

The lesion is lytic and has well-defined margins, described as “punched out” (Fig. 9.27).

Cortex may be destroyed, and a periosteal reaction with a soft tissue mass simulating a malignant bone tumor may be present.

Often there are different amounts of bone destruction of the involved cortices, resulting in the appearance of a bone within a bone.

There may be expansion of the involved bone.

Any bone may be involved.

Histology

The proliferating Langerhans cell, with an indented or grooved nucleus, is the characteristic cell.

Cytoplasm is eosinophilic.

Nuclear membrane has a crisp border.

Mitotic figures may be common.

Bilobed eosinophils with bright, granular, eosinophilic cytoplasm are present in large numbers.

Electron microscopy shows a tennis racquet–shaped Birbeck granule.

Treatment: LCH is a self-limiting process that often resolves after biopsy and/or curettage.

LCH polyostotic plus visceral disease: Hand-Schüller-Christian disease

Bone lesions and visceral involvement

Classic triad, which occurs in fewer than one fourth of patients, consists of exophthalmos, diabetes insipidus, and lytic skull lesions.

Multifocal disease is usually treated with chemotherapy.

Letterer-Siwe disease occurs in young children and is usually fatal.

39
Q
A